Areteia Therapeutics Email Format
Biotechnology ResearchNorth Carolina, United States11-50 Employees
**This company started winding down in November 2025. Page maintained for historical employment verification.** Areteia Therapeutics was a biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma.